He has 35+ years of experience in understanding of business and products, analytical ability, eye for detail and computer literacy and knowledge of recent trends.
The company plans to advance Ropanicant into double-blind, placebo-controlled Phase-2b clinical study in MDD patients, anticipated to start in early 2025
Chobhe brings over 30 years of extensive experience in quality and regulatory management within the pharmaceutical industry
The average time of dilation lasts three to eight hours
From only 80 Jan Aushadhi Kendras in 2014, there are around 11,000 units operating across the country today
The 200 bedded hospital owned & operated by Alexis
Prior to joining Alembic, he was working with Lupin Limited for more than 11 years
Dr. Jitendra Singh inaugurates 300 LPM capacity Oxygen Plant, Day Care Chemotherapy Unit affiliated to Tata Memorial Hospital & Maternal ICU at GMC Kathua
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Subscribe To Our Newsletter & Stay Updated
